This document collects and analyzes data on the evolution of COVID-19, collected by Johns Hopkins University and published daily by the European Documentation Center of Almería during the months of May, June and July 2020. COVID-19: Europe Overview Evolution of confirmed cases Europe At the end of May, the European continent registered a total of […]
Read More
Countries led by women coped better with COVID-19
Women world leaders have handled the coronavirus pandemic more effectively than their male counterparts. Countries with women at the helm like German Chancellor Angela Merkel and Prime Ministers Mette Frederiksen and Sanna Marin of Denmark and Finland, respectively, have received worldwide praise for their success in handling the COVID-19 crisis. That’s not to say that […]
Read More
Remdesivir: European Commission guarantees access
On 28th July the European Commission signed a contract with the pharmaceutical company Gilead to guarantee treatment doses of Veklury, which is the trade name of remdesivir. Veklury was the first drug authorised on an EU level for the treatment of COVID-19. From early August, batches of Veklury will be made available to Member States […]
Read More
Coronavirus: EU Humanitarian Airlift to Iraq and New Funding
Iraq is suffering from the coronavirus pandemic. Through its humanitarian partners, the EU is supporting medical facilities and health professionals in the country, as well as the implementation of public health measures in camps and places of detention, and raising awareness of how to mitigate the risks. The last in a series of EU humanitarian […]
Read More
Coronavirus Present situation in Europe. Russia 816.680 cases
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the new coronavirus of 2019. COVID-19 is the name given to the disease associated with the virus. SARS-CoV-2 is a new strain of coronavirus that has not previously been identified in humans. Next table shows european countries with reported laboratory-confirmed COVID-19 cases and deaths. Data […]
Read More
Allergenicity assessment of GM plants: stakeholders to support working group
EFSA is setting up a stakeholder consultative group to support its upcoming work on the allergenicity assessment of genetically modified (GM) plants. The group will be consulted at various stages during the process and will provide input to the EFSA scientific working group in charge of the activity. Nominations for membership of the stakeholder group […]
Read More
How COVID-19 damages the lungs
A team of EU-backed researchers has compared the lungs of coronavirus victims and patients dead from influenza-associated respiratory failure. Why does the coronavirus impact the lungs so brutally? Partially supported by the EU-funded XHaLe project, a team of researchers set out to help answer this question and achieved new insights into the effects of SARS-CoV-2 […]
Read MoreCovid-19: Support for vaccine research with additional €100 million
The Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership created in 2017 to develop vaccines to prevent future epidemics, has launched a call to support the rapid development and global manufacture of COVID-19 vaccines. The EU will co-fund the call with €100 million. The EU support is part of the pledge to invest €1 billion from Horizon […]
Read More
COVID-19: how the EU is fighting youth unemployment
According to the International Labour Organization (ILO), the pandemic is having a “devastating and disproportionate” impact on youth employment, while recent figures show that young people face major obstacles in continuing their training and education, changing jobs and accessing the labour market. Before the pandemic, youth unemployment in the EU (15-24 years old) was 14.9%, […]
Read More